1.
Br J Cancer
; 123(5): 694-697, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-612104
ABSTRACT
Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19.